Company · CIK 1314026

# Aspreva Pharmaceuticals CORP

| CIK | [1314026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001314026) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | A1 |
| Business address | British Columbia, Canada |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2005-05-13 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-122234 | IPO Final prospectus | 2005-01-24 | 2005-03-04 | 6 |

## Filings

 6

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2005-03-04 | [424B4](https://www.sec.gov/Archives/edgar/data/1314026/000094523405000141/0000945234-05-000141-index.htm) Final prospectus | 333-122234 | 0000945234-05-000141 |
| 2005-03-01 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1314026/000094523405000114/0000945234-05-000114-index.htm) Amendment | 333-122234 | 0000945234-05-000114 |
| 2005-02-28 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1314026/000094523405000106/0000945234-05-000106-index.htm) Amendment | 333-122234 | 0000945234-05-000106 |
| 2005-02-15 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1314026/000094523405000087/0000945234-05-000087-index.htm) Amendment | 333-122234 | 0000945234-05-000087 |
| 2005-02-11 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1314026/000094523405000071/0000945234-05-000071-index.htm) Amendment | 333-122234 | 0000945234-05-000071 |
| 2005-01-24 | [F-1](https://www.sec.gov/Archives/edgar/data/1314026/000094523405000025/0000945234-05-000025-index.htm) Registration filed | 333-122234 | 0000945234-05-000025 |

[All filings of this company](https://equitycapital.markets/filings?cik=1314026) · [CSV](https://equitycapital.markets/filings.csv?cik=1314026)

---
Source page: https://equitycapital.markets/company/1314026 · Data: U.S. SEC EDGAR · CC BY 4.0